Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.
Newly approved treatments for several neurologic disorders-including various types of pain, generalized myasthenia gravis, and Parkinson Disease-will be topics of discussion at AAN 2018. Here’s a brief overview of those medications FDA approved within the past 6 months.
Here's a brief overview of 6 newly approved medications indicated for management of various types of pain (post-herpetic, acute, neuropathic); for Parkinson disease and drug-induced extrapyramidal reactions; for herpes zoster prophylaxis; and for selected patients with generalized myasthenia gravis.
